Levothyroxine Sodium Tablets Recalled for Foreign Substance Contamination
Macleods Pharmaceuticals is recalling Levothyroxine Sodium Tablets (112 mcg, Lot #MLF2401A) due to a black hair found embedded in tablets.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class III recalls with low-risk contamination (foreign substance without reported illness) and no evidence of harm are classified as Moderate per the rubric criterion 'low-risk contamination, voluntary precautionary recalls.'
Plain-English summary
Macleods Pharmaceuticals Ltd is recalling Levothyroxine Sodium Tablets, USP 112 mcg (Lot #MLF2401A, Expiration 01/31/2026), distributed nationwide in the USA. The product is available in 1,344 bottles of 1,000 tablets each. The medication is manufactured in India by Macleods Pharmaceuticals Ltd for Macleods Pharma USA, Inc. (Princeton, NJ).
The recall was issued due to the presence of a black hair embedded in tablets.
Consumers who have this medication with the affected lot number should contact their pharmacist or healthcare provider regarding this recall. Patients should not use the affected lot and should obtain replacement medication from their pharmacy.
The recalled product
- Product
- LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)
- Brand
- LEVOTHYROXINE SODIUM
- Manufacturer
- Macleods Pharmaceuticals Ltd
- Category
- Drug
- Hazard
- foreign-object
- contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: MLF2401A
- Exp 01/31/2026
UPCs (13)
- 0333342393104
- 0333342397102
- 0333342404107
- 0333342393111
- 0333342400109
- 0333342403100
- 0333342393449
- 0333342394101
- 0333342402103
- 0333342396105
- 0333342395108
- 0333342398109
- 0333342399106
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · LEVOTHYROXINE SODIUM
- HighLevothyroxine Sodium Tablets Recalled Nationwide for Subpotent Content
FDA (Drugs) · 2026-04-01
- HighLevothyroxine Tablets Recall for Wrong Strength Product Mix-Up
FDA (Drugs) · 2026-01-21
- HighLevothyroxine Sodium Tablets Recalled for Subpotency Issue Nationwide
FDA (Drugs) · 2025-10-15
- ModerateLevothyroxine Sodium Tablets Recalled Due to Subpotent Drug Content
FDA (Drugs) · 2025-07-23
- HighLevothyroxine Sodium Tablets Recalled Due to Below-Specification Potency
FDA (Drugs) · 2025-07-23
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27